Clinical trial

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

NCT06064058

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention Ghazwan program Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Standard management Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-01-30

PhaseNA

Conditions

Back Pain Lower Back Chronicunresolved

Back Painunresolved

Pre Diabetescandidate · MONDO: prediabetes syndrome

Diabetesverified · MONDO: diabetes mellitus

Back Pain, Lowunresolved

Interventions

Ghazwan programDIETARY_SUPPLEMENT

Standard managementDRUG

Sponsors & collaborators

University of Baghdadlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06064058 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.